Volume 30, Number 4—April 2024
Dispatch
Acanthamoeba Infection and Nasal Rinsing, United States, 1994–2022
Table 1
Demographic | Value |
---|---|
Median age (range), y |
60 (32–80) |
Sex | |
M | 7 |
F |
3 |
Race | |
White | 5 |
Black | 2 |
Asian/Pacific Islander | 1 |
Unknown |
2 |
Ethnicity | |
Hispanic | 1 |
Non-Hispanic | 4 |
Unknown |
5 |
Disease manifestation, confirmed or suspected† | |
Rhinosinusitis | 9 |
GAE | 6 |
Cutaneous | 6 |
Osteomyelitis | 3 |
Pulmonary | 1 |
Endophthalmitis |
1 |
Diagnostic method† | |
PCR | 7 |
Histopathology | 6 |
Immunohistochemical staining | 5 |
Indirect immunofluorescence |
2 |
Specimens tested† | |
Skin | 6 |
Brain | 4 |
Sinus | 4 |
Bone |
3 |
Genotype | |
T4 | 4 |
T1 | 1 |
Unknown |
5 |
Underlying conditions† | |
Chronic sinusitis | 7 |
Cancer‡ | 5 |
Chronic kidney disease | 5 |
HIV/AIDS | 2 |
Solid organ transplant | 2 |
Stem cell transplant | 1 |
Microscopic Polyangiitis |
1 |
Outcome | |
Survived | 7 |
Died | 3 |
*Values are no. (%) patients except as indicated. GAE, granulomatous amebic encephalitis. †Some patients may have had multiple disease manifestations, multiple diagnostic methods, or multiple comorbid conditions. ‡Four chronic lymphocytic leukemia, 1 acute myeloid leukemia.
Page created: March 01, 2024
Page updated: March 20, 2024
Page reviewed: March 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.